APA

Hahn M., Bürckert J., Luttenberger C. A., Klebow S., Hess M., Al-Maarri M., Vogt M., Reißig S., Hallek M., Wienecke-Baldacchino A., Buch T., Muller C. P., Pallasch C. P., Wunderlich F. T., Waisman A. & Hövelmeyer N. (20181211). Aberrant splicing of the tumor suppressor CYLD promotes the development of chronic lymphocytic leukemia via sustained NF-κB signaling. : Leukemia.

Chicago

Hahn M, Bürckert J-P, Luttenberger C A, Klebow S, Hess M, Al-Maarri M, Vogt M, Reißig S, Hallek M, Wienecke-Baldacchino A, Buch T, Muller C P, Pallasch C P, Wunderlich F T, Waisman A and Hövelmeyer N. 20181211. Aberrant splicing of the tumor suppressor CYLD promotes the development of chronic lymphocytic leukemia via sustained NF-κB signaling. : Leukemia.

Harvard

Hahn M., Bürckert J., Luttenberger C. A., Klebow S., Hess M., Al-Maarri M., Vogt M., Reißig S., Hallek M., Wienecke-Baldacchino A., Buch T., Muller C. P., Pallasch C. P., Wunderlich F. T., Waisman A. and Hövelmeyer N. (20181211). Aberrant splicing of the tumor suppressor CYLD promotes the development of chronic lymphocytic leukemia via sustained NF-κB signaling. : Leukemia.

MLA

Hahn M, Bürckert J-P, Luttenberger C A, Klebow S, Hess M, Al-Maarri M, Vogt M, Reißig S, Hallek M, Wienecke-Baldacchino A, Buch T, Muller C P, Pallasch C P, Wunderlich F T, Waisman A and Hövelmeyer N. Aberrant splicing of the tumor suppressor CYLD promotes the development of chronic lymphocytic leukemia via sustained NF-κB signaling. : Leukemia. 20181211.